These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22560948)

  • 61. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale.
    Lee GK; Wang HH; Liu KQ; Cheung Y; Morisky DE; Wong MC
    PLoS One; 2013; 8(4):e62775. PubMed ID: 23638143
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
    Copland E; Canoy D; Nazarzadeh M; Bidel Z; Ramakrishnan R; Woodward M; Chalmers J; Teo KK; Pepine CJ; Davis BR; Kjeldsen S; Sundström J; Rahimi K;
    Lancet Oncol; 2021 Apr; 22(4):558-570. PubMed ID: 33794209
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predictors of the incidence of all-cause mortality and deaths due to diabetes and renal diseases among patients newly prescribed antihypertensive agents: a cohort study.
    Wong MC; Tam WW; Wang HH; Cheung CS; Tong EL; Sek AC; Cheung NT; Yan BP; Yu CM; Leeder SR; Griffiths SM
    Int J Cardiol; 2013 Oct; 168(5):4705-10. PubMed ID: 23931979
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data.
    Lachaine J; Petrella RJ; Merikle E; Ali F
    Can J Cardiol; 2008 Apr; 24(4):269-73. PubMed ID: 18401466
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antihypertensive medication classes used among medicare beneficiaries initiating treatment in 2007-2010.
    Kent ST; Shimbo D; Huang L; Diaz KM; Kilgore ML; Oparil S; Muntner P
    PLoS One; 2014; 9(8):e105888. PubMed ID: 25153199
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020.
    Ødegaard KM; Lirhus SS; Melberg HO; Hallén J; Halvorsen S
    ESC Heart Fail; 2023 Feb; 10(1):405-415. PubMed ID: 36266969
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association Between Angiotensin Receptor Blocker Therapy and Incidence of Epilepsy in Patients With Hypertension.
    Doege C; Luedde M; Kostev K
    JAMA Neurol; 2022 Dec; 79(12):1296-1302. PubMed ID: 36251288
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment with Free Triple Combination Therapy of Atorvastatin, Perindopril, Amlodipine in Hypertensive Patients: A Real-World Population Study in Italy.
    Perrone V; Veronesi C; Gambera M; Nati G; Perone F; Tagliabue PF; Degli Esposti L; Volpe M
    High Blood Press Cardiovasc Prev; 2019 Oct; 26(5):399-404. PubMed ID: 31463886
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Drug adherence in treatment resistant and in controlled hypertension-Results from the Swedish Primary Care Cardiovascular Database (SPCCD).
    Holmqvist L; Boström KB; Kahan T; Schiöler L; Qvarnström M; Wettermark B; Hjerpe P; Hasselström J; Manhem K
    Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):315-321. PubMed ID: 29349834
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hypertension medication use and adherence among adults with developmental disability.
    Vacek JL; Hunt SL; Shireman T
    Disabil Health J; 2013 Oct; 6(4):297-302. PubMed ID: 24060252
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Uptake of angiotensin II receptor blockers in the treatment of hypertension.
    Greving JP; Denig P; van der Veen WJ; Beltman FW; Sturkenboom MC; de Zeeuw D; Haaijer-Ruskamp FM
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):461-6. PubMed ID: 15912393
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Medication Adherence and Blood Pressure Control Among Hypertensive Patients With Coexisting Long-Term Conditions in Primary Care Settings: A Cross-Sectional Analysis.
    Li YT; Wang HHX; Liu KQL; Lee GKY; Chan WM; Griffiths SM; Chen RL
    Medicine (Baltimore); 2016 May; 95(20):e3572. PubMed ID: 27196458
    [TBL] [Abstract][Full Text] [Related]  

  • 74. First-line treatment of essential hypertension: A real-world analysis across four antihypertensive treatment classes.
    Stapff M; Hilderbrand S
    J Clin Hypertens (Greenwich); 2019 May; 21(5):627-634. PubMed ID: 30980608
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Patient Adherence to Olmesartan/Amlodipine Combinations: Fixed Versus Extemporaneous Combinations.
    Levi M; Pasqua A; Cricelli I; Cricelli C; Piccinni C; Parretti D; Lapi F
    J Manag Care Spec Pharm; 2016 Mar; 22(3):255-62. PubMed ID: 27003555
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Adherence and related cardiovascular outcomes to single pill vs. separate pill administration of antihypertensive triple-combination therapy.
    Rea F; Morabito G; Savaré L; Pathak A; Corrao G; Mancia G
    J Hypertens; 2023 Sep; 41(9):1466-1473. PubMed ID: 37432906
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
    Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
    J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.
    Suchard MA; Schuemie MJ; Krumholz HM; You SC; Chen R; Pratt N; Reich CG; Duke J; Madigan D; Hripcsak G; Ryan PB
    Lancet; 2019 Nov; 394(10211):1816-1826. PubMed ID: 31668726
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
    Gadzhanova S; Roughead EE; Bartlett LE
    Eur J Clin Pharmacol; 2016 Jun; 72(6):765-71. PubMed ID: 26961086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.